Ossisko Life Sciences Private Limited
About Ossisko Life Sciences Private Limited
Data last updated:
Ossisko Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2019PTC357789. Its GSTIN is 03AADCO0657M1ZF (Punjab). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.14 Lakh. It is led by directors including Ravi Goyal and Manuj Singla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room 203 2nd Floor Z – A/3 Kundan Mansion, Asaf Ali Road Turkman Gate New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.01 Cr, a growth of 61% compared to the previous year. For the same year it recorded a net profit of ₹6.35 Lakh (net margin 2.1%) and EBITDA of ₹11.28 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 91% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRoom 203 2nd Floor Z – A/3 Kundan Mansion, Asaf Ali Road Turkman Gate New Delhi, Delhi, India – 110002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ossisko Life Sciences Private Limited
The main business activity of Ossisko Life Sciences is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ossisko Life Sciences Private Limited FY 2025 filings available
Ossisko Life Sciences Private Limited reported revenue of ₹3.01 Cr (up 61% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ossisko Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 91% over five years, including 61% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ossisko Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹11.28 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ossisko Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ossisko Life Sciences are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ossisko Life Sciences Private Limited
Ossisko Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Novo Pharm Formulations Private Limited | ₹3.01 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Vadodara, Gujarat, India |
| Ajanta Medicals Private Limited | ₹3.01 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Bethora, Goa, India |
| Synovion Laboratories Private Limited | ₹3.01 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Delhi, India |
| Gelcotin Biotech Private Limited | ₹3.01 Cr (FY 2025) | •••• | •••• | 18712.0% | •••• | Bhubaneswar, Odisha, India |
| Sharing Formulations Private Limited | ₹3.01 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Ahmedabad, Gujarat, India |
| Ossisko Life Sciences Private Limited this company | ₹3.01 Cr (FY 2025) | •••• | •••• | 61.0% | •••• | New Delhi, Delhi, India |
| Aishika Pharma Private Limited | ₹3 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Icon Formulations Private Limited | ₹2.99 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Hyderabad, Telangana, India |
| Realmed Pharma Private Limited | ₹2.99 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Chandigarh, India |
| Spectrum Pharmachem Private Limited | ₹2.99 Cr (FY 2024) | •••• | •••• | 1495500.0% | •••• | Palghar, Maharashtra, India |
| Fuzen Pharmaceuticals Private Limited | ₹2.98 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Ossisko Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ossisko Life Sciences Private Limited
Ossisko Life Sciences Private Limited is audited by ARUN MEHTA & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ARUN MEHTA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ossisko Life Sciences Private Limited
Ossisko Life Sciences has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Goyal | Director | 01 Sep 2021 | 5 Years 1 Months | Current |
| Manuj Singla | Director | 01 Sep 2021 | 5 Years 1 Months | Current |
| Manpreet Singh | Director | 01 Sep 2021 | 5 Years 1 Months | Current |
Ownership and Shareholding of Ossisko Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ossisko Life Sciences Private Limited
Ossisko Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ossisko Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Ossisko Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ossisko Life Sciences Private Limited
Ossisko Life Sciences Private Limited has 9 board changes on record since 2020: 3 appointments and 6 cessations. The latest: Manpreet Singh ceased to be Additional Director on 30 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Ossisko Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ossisko Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ossisko Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ossisko Life Sciences Private Limited
Ossisko Life Sciences has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCO0657M1ZF | Punjab | Active | 01 Feb 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ossisko Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ossisko Life Sciences Private Limited
Ossisko Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 November 2019 (7+ years old) and is registered under CIN U24290DL2019PTC357789.
Ossisko Life Sciences reported revenue of ₹3.01 Cr for FY 2025 (up 61% YoY).
Ossisko Life Sciences has 3 current directors:
- Ravi Goyal - Director
- Manuj Singla - Director
- Manpreet Singh - Director
Ossisko Life Sciences reported a net profit of ₹6.35 Lakh (net margin 2.1%) and EBITDA of ₹11.28 Lakh (EBITDA margin 3.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ossisko Life Sciences is 9% over three years and 91% over five years. In the latest year (FY 2025) revenue rose 61%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ossisko Life Sciences is 03AADCO0657M1ZF, registered in Punjab. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Ossisko Life Sciences is U24290DL2019PTC357789. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ossisko Life Sciences was incorporated on 20 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ossisko Life Sciences by revenue are Novo Pharm Formulations Private Limited, Ajanta Medicals Private Limited, Synovion Laboratories Private Limited, Gelcotin Biotech Private Limited, Sharing Formulations Private Limited and 5 more, all in the Pharma industry (Formulations).
Manpreet Singh ceased to be Additional Director on 30 Nov 2021. Manuj Singla ceased to be Additional Director on 30 Nov 2021. Raj Kumar Goyal ceased to be Additional Director on 30 Nov 2021. Ossisko Life Sciences has 9 board changes on record in total.
The registered office of Ossisko Life Sciences is at Room 203 2nd Floor Z – A3 Kundan Mansion, Asaf Ali Road Turkman Gate New Delhi, Delhi, India – 110002.